Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Cuttsy+Cuttsy welcomes new team members

August 13, 2025 | Account Executive, Artworker, Team, graphic designer, new 

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker

New team members

We’re excited to announce three brilliant new additions to the Cuttsy+Cuttsy team this month, each brining unique talents and fresh perspectives to help us deliver meaningful, impactful work across all our projects.

Joining us are:

  • Flo, taking on the role of Account Executive, brings a blend of enthusiasm and organisational expertise, along with a keen focus on fostering strong client relationships.
  • Vicki, our newest Graphic Designer, offers fresh creative insights and a passion for crafting designs that truly resonate.
  • Jo, stepping into the role of Artworker, brings precision and dedication to refining every detail in the work we produce.

Commenting on the new appointments, Managing Director Harriet Karia said, “We’re delighted to welcome Flo, Vicki and Jo to the team. They bring fresh ideas, individual strengths and a shared drive to make a difference. I’m looking forward to the impact they’ll have as we continue creating work that really matters, especially for patients.”

These new appointments reflect our commitment to building a talented and diverse team that drives excellence in everything we do. We’re confident Flo, Vicki, and Jo will bring valuable perspectives and skills to their roles, and we’re eager to see the impact of their work.

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Permission to pause: making treatment breaks part of the cancer care conversation

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Why faster trials make participant understanding more important than ever

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.

Older trial participants reject bad design, not technology

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.